Navigation Links
The Uptake of Novel Therapies Will Drive the Obesity Drug Market to Increase More than Six-Fold to Over $3.2 Billion in 2018
Date:9/15/2009

WALTHAM, Mass., Sept. 15 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the uptake of novel therapies will drive the obesity drug market to increase more than six-fold, from $512 million in 2008 to more than $3.2 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Obesity finds that the high level of unmet need for efficacious and safe weight-loss therapies will propel the uptake of novel therapies and boost diagnosis and drug-treatment rates of obesity in the world's major pharmaceutical markets. According to the report, physician and patient dissatisfaction with the weight-loss efficacy of current market-leading therapies such as Roche's Xenical, GlaxoSmithKline's OTC Alli and Abbott's Meridia has created an environment that is conducive to the rapid uptake of novel agents. The most notable novel therapies that are expected to launch by 2018 include Arena Pharmaceuticals' lorcaserin and Amylin Pharmaceuticals' pramlintide/leptin combination. The combined sales of lorcaserin and pramlintide/leptin will capture 87 percent of the total obesity market in 2018, according to the report.

The report also finds that the absence of cannabinoid receptor-1 antagonists in the marketplace has created enormous opportunity for drugs with other novel mechanisms of action. Owing to safety concerns, the withdrawal of the cannabinoid-1 receptor antagonist rimonabant (Sanofi-Aventis's Acomplia) from the European markets and the compound's failure to gain U.S. regulatory approval has led several major drug companies to discontinue development of obesity drugs in this class.

"Regulatory agencies and physicians have become increasingly concerned about psychiatric side effects following rimonabant's recent with
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
2. Varian and BrainLAB Announce Rapid Uptake of Powerful and Versatile Radiosurgery Platform
3. Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016
4. Uptake of Next-Generation Antifungals Has Intensified Competition in the Severe Fungal Infections Drug Market
5. 2008 Sees Significant Rise in Prescription Abandonment and Uptake of Generics
6. Frost & Sullivan: Clinical and Cost Benefits to Promote Uptake of Advanced Wound Management Technologies Across Europe
7. The Launch and Uptake of More Than 20 Novel Drugs Over The Next 10 Years Will Drive $12.5 Billion Growth in the Type 2 Diabetes Market
8. Electronic Medical Record Technology Uptake Faces Challenges
9. Generic Erosion of Established Agents Will Offset Growth From Uptake of Emerging Therapies in the Market for Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms
10. Medical Imaging Equipment Finds Significant Uptake in Ghana, Finds Frost & Sullivan
11. Novel virus detection identifies new viruses in study of respiratory infections and asthma attacks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... By Steven Reinberg ... -- Simple blood tests may one day help predict survival ... lateral sclerosis (ALS), also called Lou Gehrig,s disease, Italian researchers ... yield clues to how fast ALS is progressing are called ... kidney and liver health, according to the U.S. National Library ...
(Date:7/22/2014)... (Boston)-- Researchers from Boston University School of Medicine ... that participants who received care through BMC,s Violence ... physical, mental, emotional and social needs of violently ... injuries and experienced life changing behaviors through connections ... feel trust and hope. These findings are reported ...
(Date:7/22/2014)... European Bio stimulants Market report defines and segments the ... of revenue. The bio stimulants market in Europe is ... to $940.6 million by 2018, at a CAGR of ... TOC of the Europe Bio stimulants Market report, to ... http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html , Agriculture contributes to 10% of ...
(Date:7/22/2014)... In a special day of pampering ... School of Beauty joined forces with The Discovery ... a free “Make-over Day.” In a win-win event, Marinello ... the community, and The Discovery House clients had a ... some first-hand experience about career possibilities. , “The ...
(Date:7/22/2014)... 22, 2014 Expert Publishing ... Services , announces the launch of PoisonEXPERT™ ... and safety professionals employed by organizations that use ... to manage the impact of chemicals on their ... to relevant chemical-specific information and medical protocols that ...
Breaking Medicine News(10 mins):Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 2Health News:Blood Test Might Help Predict Survival With Lou Gehrig's Disease 3Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 2Health News:The Discovery House 'Make-over Day' Adds Pampering To Recovery 3Health News:PoisonEXPERT™ from ExPub Now Available 2Health News:PoisonEXPERT™ from ExPub Now Available 3
... turning their backs on tanning amid growing concerns over skin ... survey shows that teenagers are resisting the urge to tan ... 5,073 Australian adults and 699 Australian teenagers aged 12 to ... that 68 % of those aged 12-17 said they had ...
... University have found a new model that shows how ... in the presence of microenvironment of tumor cells. // ... skin cell to malignant cell is understood with the ... offer new insights into the influence of the tumor ...
... the developing fetus, a womb confers safety and security to ... a womb is even necessary for normal brain development. // ... found to have a poor brain development when compared to ... done regarding brain development of babies born around 26 weeks ...
... bottle-feeding may impose an increased risk of iron deficiency ... American children) according to // a new study by ... Wisconsin. , ,"This is the first study that ... prolonged bottle-feeding and iron deficiency, among a nationally representative ...
... in the UK has revealed that smokers are unconcerned with ... particular they seemed to be aware of the damage // ... lip and even the teeth, but were strangely reluctant to ... oral and maxillofacial surgeons, who are launching a massive awareness ...
... across the walls of a patient's room have been ... hypertension and rheumatic complaints, a study says.//,A study group ... kept in medicated rooms were cured in shorter less ... study involved 36 patients, of whom 19 were kept ...
Cached Medicine News:Health News:Aussie teens applauded for declining sun tan 2Health News:New Model for understanding Tumor Metastasis 2Health News:Brain development compromised in premature babies 2Health News:Iron deficiency found in children with prolonged bottle feeding 2Health News:Now medicated coir to cure ailments 2
(Date:7/22/2014)... -- Research and Markets  has announced the addition ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... monitor, and assess medical conditions, diseases, or infections usually ... earlier and more targeted treatment. These tests are minimally ... This kind of diagnostics provides early detection of diseases ...
(Date:7/22/2014)... , July 22, 2014 BiologicTx ® ... first 3-way Kidney Paired Donation transplant exchange ... procedures happened on July 9 at the Miami Transplant ... Miami, Fla. Kidney Paired ... are not compatible for kidney transplant with one another ...
(Date:7/22/2014)... , July 22, 2014  A central ... a SynCardia temporary Total Artificial Heart ... Strong Memorial Hospital with the Freedom® portable driver ... Fontana, a 64-year-old retiree from a Syracuse ... He managed the condition with medications, an implantable ...
Breaking Medicine Technology:Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 2Global IVD Market 2014-2018: Key Vendors are Abbott Laboratories, Johnson & Johnson, Roche Diagnostics and Siemens Healthcare 3BiologicTx Paired Donation Aids In Successful Kidney Transplants 2BiologicTx Paired Donation Aids In Successful Kidney Transplants 3'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 2'I'm a Heartless SOB' Jokes Patient Discharged from Strong Memorial Hospital without a Human Heart 3
... Calif., Feb. 24, 2011 Codexis, Inc. (Nasdaq: ... promoted to Chief Technology Officer and Senior Vice President, Process ... report to Alan Shaw, Ph.D., President and Chief Executive Officer. ... a 25-year career with DuPont. He served as Vice President, ...
... Par Pharmaceutical Companies, Inc. (NYSE: PRX ) ... ended December 31, 2010. For the fourth quarter ... $227 million and income from continuing operations of $17.6 million, ... million charge related to the settlement of litigation and changes ...
Cached Medicine Technology:Codexis Names David Anton CTO & SVP, Process Development & Manufacturing 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 2Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 3Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 4Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 5Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 6Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 7Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 8Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 9Par Pharmaceutical Companies Reports Fourth Quarter and Full-Year Results for 2010 10
Agarose L03 is recommended for separations of DNA fragments = 1,000 bp....
... Anion traces: chloride (Cl) ≤ 5000 mg/kg sulfate (SO ... 50 mg/kg Cd ≤ 5 mg/kg Co ≤ 5 ... Fe ≤ 10 mg/kg K ≤ 50 mg/kg Mg ... 2000 mg/kg Ni ≤ 5 mg/kg Pb ≤ 5 ...
... ≤ 5000 mg/kg sulfate (SO 4 ) ≤ 5000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 5 ... K ≤ 50 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
... flexible gels for separation of ... of wide range and standard ... mg/mL, clear, faintly yellow, hot ... MP: 90 °C (1% in ...
Medicine Products: